Nunzia Pharmaceutical Corp. engages in the manufacture and sales of drugs. It offers Nunzia, a nutraceutical that treats Autism, Fragile X, attention-deficit/hyperactivity disorder (ADHD), post-traumatic stress disorder (PSTD), and other such disorders. The company was founded on November 12, 1986 and is headquartered in Long Beach, CA.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company